May cyberattack cost Scripps nearly $113M in lost revenue, more costs Diabetes startup brews up $11M after 'serendipitous spill' led to creation of new CGM tech COVID-19 tracker: Lilly to require vaccines for U.S. workers; Elderly don't need booster yet, Fauci says HIMSS21: Technology needs to be at the center of health equity efforts, Google, Kaiser Permanente execs say With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—again More fraud, tax evasion charges for telemedicine operator tied to $784M scheme Match made: Butterfly, Caption Health team up to bring AI to portable ultrasound Biden directs Congress to give Medicare broad authority to negotiate for lower drug prices Pfizer halted Chantix distribution then recalled a dozen batches. Now, a generic's here to help fill the shortage Featured Story | By Robert King A major cyberattack that disrupted care cost Scripps Health nearly $113 million in lost revenue and additional costs, the San Diego-based system reported. read more |
| |
|---|
|
Top Stories By Andrea Park A proof-of-concept study found that Hagar’s radio frequency technology was able to continuously measure blood glucose levels with at least 90% accuracy, compared to the estimated 70% rate for traditional continuous glucose monitors. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner Eli Lilly will require all of its workers in the U.S. and Puerto Rico to get vaccinated against the virus by Nov. 15. The director of the CDC confirmed that the FDA is working with Moderna and Pfizer over booster shots for Americans with weak immune systems, although the elderly might not be included. Plus more headlines. read more By Heather Landi The COVID-19 pandemic put a spotlight on existing healthcare disparities, but in communities throughout the U.S., public health leaders have been trying to tackle systemic inequities for years with limited success. Efforts have been siloed and technology has not been part of the conversation, industry leaders say. read more By Kevin Dunleavy An FDA approval for COVID-19 booster shots for the immunocompromised appears imminent, according to NBC News, which could then touch off nods for the elderly and the general population. read more By Dave Muoio Creaghan Harry was indicted in 2019 for his alleged role in one of the largest Medicare fraud and kickback schemes pursued by the Department of Justice. New superseding charges outline his alleged efforts to conceal the proceeds through shell companies and evade tax payments. read more By Conor Hale Two companies working to reshape the field of ultrasound have joined forces, with Caption Health looking to bring its artificial intelligence-guided exams to Butterfly Network’s handheld diagnostic probes. read more By Robert King Biden outlined a bold agenda to tackle drug prices, directing Congress to give Medicare wide authority to negotiate lower prices with drugmakers. read more By Noah Higgins-Dunn Trying to fill a recent shortage for Pfizer’s smoking med Chantix, the FDA approved Par Pharmaceuticals’ copycat version “well ahead” of its expected review date, the agency said. read more |
